agespecif
epidemiolog
data
asymptomat
symptomat
sever
infect
essenti
public
health
polici
combat
influenza
studi
incorpor
data
microbiolog
confirm
infect
seropreval
comprehens
describ
epidemiolog
pandem
influenza
seropreval
determin
random
serum
sampl
collect
hospit
januari
first
wave
pandem
march
second
wave
data
microbiolog
confirm
infect
sever
case
obtain
centr
health
protect
hong
kong
sever
case
common
age
group
microbiolog
confirm
incid
rate
highest
children
age
year
drop
sharpli
adult
popul
p
incid
rate
sever
diseas
highest
age
group
age
group
seropreval
similar
younger
age
group
proport
sever
case
rel
seropreval
significantli
higher
age
group
judg
percentag
specimen
posit
respiratori
virus
compar
pandem
viru
impact
symptomat
diseas
due
pandem
viru
higher
respiratori
virus
peopl
age
year
conclus
age
group
highest
overal
incid
highest
rate
sever
diseas
current
consid
world
health
organ
atrisk
group
priorit
influenza
vaccin
area
univers
influenza
vaccin
practic
one
major
critic
handl
pandem
influenza
world
health
organ
appar
overestim
diseas
sever
data
agespecif
incid
rate
influenza
pandem
provid
scientif
basi
formul
public
health
polici
insight
agerel
suscept
sever
influenza
current
discrep
age
cutoff
recommend
influenza
vaccin
especi
adult
world
health
organ
consid
individu
age
year
higher
risk
sever
influenza
includ
one
target
group
influenza
vaccin
antivir
treatment
prophylaxi
unit
state
center
diseas
control
prevent
extend
influenza
vaccin
person
age
month
event
vaccin
shortag
age
year
accur
assess
incid
rate
sever
diseas
choic
denomin
crucial
total
number
microbiolog
confirm
case
use
denomin
overestim
sever
case
incid
rate
infect
without
microbiolog
confirm
exclud
hand
influenzalik
ill
ili
often
use
surrog
marker
total
number
case
may
inaccur
especi
surveil
period
extend
long
period
mani
ili
may
due
respiratori
pathogen
epidemiolog
studi
use
seropreval
measur
infect
popul
studi
report
high
preval
young
adult
sever
diseas
pediatr
geriatr
popul
may
explain
immatur
immun
system
immunosenesc
respect
howev
studi
incorpor
agespecif
data
asymptomat
symptomat
sever
infect
analys
studi
sought
integr
clinic
laboratori
data
evalu
rel
impact
influenza
pandem
differ
age
group
popul
chang
seropreval
provid
estim
overal
burden
infect
wherea
incid
rate
microbiolog
confirm
infect
repres
estim
symptomat
case
sampl
collect
mostli
symptomat
patient
proport
microbiolog
confirm
case
sever
case
seroposit
popul
use
estim
burden
symptomat
sever
diseas
infect
assess
rel
impact
pandem
influenza
viru
compar
respiratori
virus
analyz
posit
rate
respiratori
specimen
test
respiratori
virus
sampl
determin
antibodi
titer
studi
approv
institut
review
board
hospit
author
hong
kong
antibodi
titer
determin
archiv
serum
sampl
randomli
select
clinic
biochemistri
divis
queen
mari
hospit
januari
first
wave
pandem
summer
march
peak
second
wave
laboratori
provid
servic
inpati
outpati
estim
catchment
popul
million
peopl
hong
kong
popul
reason
repres
total
popul
million
redund
serum
sampl
exclud
use
uniqu
ident
card
number
hong
kong
resid
sampl
code
remain
anonym
analysi
serolog
assay
antibodi
titer
pandem
influenza
viru
determin
hemagglutin
inhibit
hi
assay
previous
describ
briefli
nonspecif
inhibitor
serum
remov
receptordestroy
enzym
rde
ii
seiken
treat
serum
sampl
serial
dilut
phosphatebuff
salin
start
dilut
serum
sampl
mix
hemagglutinin
unit
pandem
influenza
viru
incub
room
temperatur
h
turkey
red
blood
cell
ad
incub
room
temperatur
min
examin
hemagglutin
hi
titer
consid
posit
microbiolog
confirm
influenza
case
pandem
influenza
viru
infect
confirm
microbiolog
may
februari
virolog
divis
public
health
laboratori
servic
branch
centr
health
protect
chp
hong
kong
includ
analysi
laboratori
process
clinic
specimen
sent
respiratori
viru
detect
govern
hospit
outpati
clinic
spread
hong
kong
respiratori
specimen
includ
nasopharyng
aspir
nasopharyng
swab
throat
swab
tracheal
aspir
bronchoalveolar
lavag
fluid
case
definit
microbiolog
confirm
case
posit
revers
transcriptionpcr
rtpcr
test
pandem
influenza
viru
gene
posit
viral
cultur
respiratori
specimen
previous
report
decis
microbiolog
test
made
attend
clinician
sever
case
period
report
chp
case
definit
sever
pandem
influenza
requir
notif
chp
includ
admiss
intens
care
unit
critic
condit
requir
assist
ventil
chang
sever
critic
fatal
microbiolog
confirm
pandem
influenza
viru
total
number
laboratori
request
test
influenza
viru
respiratori
virus
number
respiratori
tract
specimen
sent
virolog
divis
public
health
laboratori
servic
branch
chp
hong
kong
viru
detect
respiratori
virus
includ
season
influenza
viru
influenza
viru
influenza
b
viru
adenoviru
parainfluenza
viru
respiratori
syncyti
viru
rhinoviru
definit
seropreval
obtain
divid
number
serum
sampl
hi
titer
total
number
nonredund
sera
test
infect
popul
age
group
estim
percent
chang
seropreval
multipli
popul
number
incid
rate
symptomat
diseas
obtain
divid
number
microbiolog
confirm
case
popul
age
group
wherea
incid
rate
sever
diseas
obtain
divid
number
notifi
sever
diseas
case
popul
age
group
burden
symptomat
sever
diseas
estim
proport
incid
infect
popul
statist
analysi
relationship
age
incid
rate
assess
spearman
correl
chisquar
test
trend
use
assess
proport
posit
specimen
pandem
influenza
viru
respiratori
virus
differ
age
group
risk
ratio
influenza
age
group
younger
age
group
calcul
statist
analysi
perform
use
spss
softwar
version
window
spss
r
statist
environ
version
vassarstat
http
facultyvassaredulowryvassarstatshtml
seropreval
estim
hi
test
serum
sampl
sampl
collect
respect
tabl
seroposit
rate
preexist
crossreact
antibodi
pandem
influenza
viru
found
mainli
patient
age
year
preval
older
age
group
fig
crossreact
antibodi
also
found
individu
age
year
children
year
age
adult
year
old
seroposit
overal
seroposit
rate
differ
hi
titer
baselin
statist
signific
adult
year
age
older
therefor
could
use
seropreval
accur
predict
overal
incid
rate
infect
popul
may
februari
total
microbiolog
confirm
case
pandem
influenza
viru
infect
found
sever
case
report
male
femal
median
age
year
age
group
largest
number
sever
case
account
total
number
sever
case
fig
incid
rate
microbiolog
confirm
pandem
influenza
highest
age
group
drop
sharpli
increas
age
p
incid
rate
sever
case
show
appar
bimod
distribut
higher
incid
rate
age
group
older
year
fig
highest
incid
rate
sever
diseas
also
occur
age
group
significantli
higher
risk
younger
age
group
tabl
proport
microbiolog
confirm
case
sever
diseas
case
rel
infect
popul
number
use
estim
burden
symptomat
sever
diseas
infect
popul
differ
age
group
fig
burden
symptomat
diseas
highest
age
group
sever
diseas
occur
frequent
older
popul
start
rise
age
group
fig
tabl
also
assess
impact
pandem
influenza
viru
infect
rel
respiratori
viral
infect
differ
age
group
analyz
posit
rate
respiratori
tract
specimen
pandem
influenza
viru
detect
frequent
respiratori
virus
age
group
person
year
age
respiratori
virus
predomin
age
group
march
guest
http
cviasmorg
sampl
bia
term
specimen
collect
age
group
studi
systemat
analyz
compar
agespecif
incid
rate
pandem
influenza
use
serial
serolog
data
data
microbiolog
confirm
infect
encompass
age
group
pandem
influenza
viru
affect
children
adolesc
frequent
older
adult
evidenc
greater
differ
prepandem
postpandem
seropreval
higher
agespecif
incid
rate
microbiolog
confirm
infect
higher
posit
rate
respiratori
tract
specimen
respiratori
virus
age
group
account
largest
number
sever
case
age
group
also
highest
incid
rate
sever
case
analyz
posit
rate
respiratori
tract
specimen
also
shown
pandem
influenza
viru
predomin
respiratori
viru
affect
popul
age
year
less
main
advantag
use
differ
prepandem
postpandem
seropreval
estim
incid
rate
even
asymptomat
case
captur
numer
seropreval
studi
pandem
influenza
publish
unlik
studi
mani
incorpor
incid
rate
microbiolog
confirm
case
sever
case
studi
compar
seropreval
microbiolog
confirm
data
either
includ
age
group
perform
agespecif
analysi
world
health
organ
includ
adult
year
age
older
risk
group
sever
diseas
one
target
group
influenza
vaccin
antivir
treatment
prophylaxi
support
find
burden
sever
diseas
highest
age
group
consist
studi
shown
age
year
higher
casefat
ratio
howev
also
demonstr
age
group
highest
incid
rate
sever
diseas
among
age
group
higher
burden
sever
diseas
younger
age
group
result
compar
worldwid
estim
obtain
use
laboratoryconfirm
case
denomin
calcul
rate
sever
case
age
group
highest
rel
risk
admiss
intens
care
unit
countri
likewis
studi
california
show
highest
incid
rate
death
occur
age
year
howev
neither
studi
estim
burden
sever
diseas
infect
individu
monitor
chang
seropreval
first
wave
rather
use
total
popul
denomin
analysi
find
find
unlik
caus
specimen
collect
bia
posit
rate
respiratori
virus
differ
age
group
high
incid
rate
sever
diseas
age
group
therefor
justifi
lower
age
cutoff
highrisk
group
year
old
burden
symptomat
diseas
lowest
age
group
includ
person
age
year
suggest
mani
patient
mild
diseas
requir
medic
attent
therefor
test
respiratori
virus
age
group
result
consist
find
anoth
larg
prospect
studi
pa
tient
age
group
mildli
symptomat
burden
sever
diseas
also
lower
age
group
includ
person
age
year
older
age
group
despit
low
burden
sever
diseas
absolut
number
sever
case
age
group
actual
higher
year
old
similar
case
previou
studi
larg
proport
popul
age
group
infect
due
lack
preexist
crossreact
antibodi
pandem
influenza
viru
also
specul
particular
age
group
develop
solid
cellmedi
immun
due
cytotox
lymphocyt
respons
nonneutr
antibodydepend
cellular
cytotox
highli
conserv
viral
antigen
viral
matrix
nucleoprotein
import
recoveri
ill
rel
protect
induc
repeat
exposur
age
year
decay
ageassoci
immunosenesc
impair
major
underli
diseas
year
age
overal
postpandem
seropreval
studi
lower
rang
estim
previou
seropreval
studi
shown
estim
infect
rate
wide
rang
estim
may
account
differ
ethnic
group
studi
popul
serolog
assay
use
hi
versu
viral
neutral
assay
time
specimen
collect
first
second
wave
studi
also
note
bimod
distribut
prepandem
seropreval
crossreact
antibodi
hi
titer
found
small
number
individu
age
year
age
year
find
consist
studi
seroposit
rate
slightli
higher
born
howev
observ
seen
studi
reason
low
level
crossreact
antibodi
known
sever
limit
studi
factor
associ
lower
rate
seroconvers
describ
includ
older
age
femal
pregnant
milder
diseas
notabl
convalescentphas
plasma
donor
influenza
viru
hi
titer
factor
contribut
lower
seropreval
rate
lead
underestim
incid
infect
contrast
vaccin
lead
seroconvers
therefor
seropreval
may
overestim
incid
infect
area
vaccin
coverag
high
howev
pandem
vaccin
uptak
rate
low
hong
kong
one
wide
public
report
suspect
influenzarel
complic
guillainbarr
syndrom
medic
doctor
march
individu
hong
kong
influenza
vaccin
program
total
hong
kong
popul
receiv
monoval
pandem
vaccin
addit
dose
vaccin
distribut
privat
practition
individu
exclud
atrisk
target
group
vaccin
program
howev
exact
number
vaccine
privat
sector
outsid
govern
vaccin
program
known
data
report
chp
even
batch
vaccin
administ
patient
percentag
vaccin
popul
would
therefor
effect
vaccin
neglig
furthermor
number
avail
prepandem
serum
sampl
age
group
low
may
abl
detect
individu
seroposit
howev
sinc
studi
age
group
show
low
preval
rate
preexist
antibodi
interpret
result
similar
age
group
unexpectedli
unexplain
small
chang
seropos
age
group
final
differ
rate
sever
infect
may
confound
factor
underli
diseas
studi
found
higher
incid
sever
infect
age
group
hong
kong
popul
age
group
chronic
diseas
compar
age
less
year
abl
access
clinic
data
patient
serum
sampl
code
anonym
studi
incorpor
underli
diseas
allow
assess
independ
effect
age
sever
age
group
adolesc
younger
adult
commonli
affect
pandem
influenza
viru
clinic
consequ
alarm
older
adult
contrast
usual
age
cutoff
year
result
clearli
demonstr
individu
year
age
prone
sever
infect
younger
popul
view
find
health
author
consid
lower
atrisk
group
year
age
year
age
